Clinical scienceThe role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single-center prospective randomized trial
Section snippets
Patients
A prospective, randomized, double-blind, placebo-controlled trial was conducted at the tertiary Istanbul University Institute of Oncology between September 2008 and December 2009. All patients who were referred to the authors (H.K., S.K.) for TIVAD insertion were considered as candidates for the trial. A total of 432 consecutive patients who met criteria for TIVAD implantation were randomly assigned either cefazolin or placebo.
Exclusion criteria were refusal to participate and other reasons
Patient characteristics
In total, 432 patients initially were enrolled in this study. Thirteen patients who had one or more of the exclusion criteria were excluded. In addition, 15 of 419 patients were excluded from the efficacy analysis because of a violation of the study protocol or failure to complete follow-up examinations. A total of 419 patients (cefazolin, 210; placebo, 209) constituted the intent-to-treat population, and 404 were valid for the efficacy analysis (Fig. 1). Ten patients who were not available for
Comments
The reported frequency of catheter-related infections in TIVADs varies from .6% to 27%.10, 11, 12, 13, 14, 16 Schwarz et al13 reported that the infection rate was 8.8% in 616 patients. Of the 62 infectious complications, 31 (50%) presented as sepsis, and 15 (24%) presented as local infections with cellulitis around the port. Thirty-seven (60%) ultimately necessitated removal of the catheter. Biffi et al17 reported on a series of 333 patients with TIVADs; the rate of surgical site infection was
References (22)
- et al.
Outcomes of surgical and radiologic placed implantable central venous access ports
Am J Surg
(2009) - et al.
A prospective randomized trial demonstrating valved implantable ports have fewer complications and lower overall cost than nonvalved implantable ports
Am J Surg
(2004) - et al.
Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: a randomized trial
Ann Oncol
(2009) - et al.
Totally implantable venous-access ports: local problems and extravasation injury
Lancet Oncol
(2002) - et al.
Management of venous port systems in oncology: a review of current evidence
Ann Oncol
(2008) - et al.
Comparison of diagnostic specimens and methods to evaluate infected venous access ports
Am J Surg
(1995) - et al.
The timing and sequence of multiple device-related complications in patients with indwelling subcutaneous ports
Am J Surg
(1997) - et al.
Catheter-related infections: diagnosis and intravascular treatment
Clin Microbiol Infect
(2002) - et al.
Diagnosis and management of long-term central venous catheter infections
J Vasc Interv Radiol
(2004) - et al.
Guidelines for the prevention of intravascular catheter-related infections
Am J Infect Control
(2002)
Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients
Oncology
Cited by (40)
Does systemic antibiotic prophylaxis prior to the placement of totally implantable venous access devices reduce early infection? A retrospective study of 1,485 cases at a large academic institution
2020, American Journal of Infection ControlCitation Excerpt :In this study, patients either received prophylactic cefazolin (n = 203) or placebo (n = 201). The results from this study found no significant difference between superficial surgical site infection between the 2 groups with a P value of .75.22 The findings of our study, with a 0.54% 30-day TIVAD removal rate and a 2.90% TIVAD removal for all catheter-related bloodstream infections, are in-line with reported literature.
Adult and Pediatric Antibiotic Prophylaxis during Vascular and IR Procedures: A Society of Interventional Radiology Practice Parameter Update Endorsed by the Cardiovascular and Interventional Radiological Society of Europe and the Canadian Association for Interventional Radiology
2018, Journal of Vascular and Interventional RadiologyACR Appropriateness Criteria<sup>®</sup> Radiologic Management of Central Venous Access
2017, Journal of the American College of RadiologyRoutine Antibiotic Prophylaxis for Totally Implantable Venous Access Device Placement: Meta-Analysis of 2,154 Patients
2016, Journal of Vascular and Interventional RadiologyESCMID* guideline for the diagnosis and treatment of biofilm infections 2014
2015, Clinical Microbiology and InfectionComparative study of valved and nonvalved fully implantable catheters inserted via ultrasound-guided puncture for chemotherapy
2014, Annals of Vascular Surgery